Crinetics Pharmaceuticals Shares Rise 13% on Carcinoid Syndrome Treatment Trial
Crinetics Pharmaceuticals 3Q Loss/Shr $1.01 >CRNX
Crinetics Pharmaceuticals Shares Rise 17% After Soaring Monday
Crinetics Pharmaceuticals Just Scored A Much-Needed Win And Soared 63%
Tesla and Canopy Growth stocks surge, RTX and J.M. Smucker shares fall, and other stocks on the move
Crinetics Shares Surge Premarket on Phase 3 Paltusotine Success >CRNX
Crinetics Pharmaceuticals 2Q Loss/Shr 94c >CRNX
Crinetics Pharmaceuticals 1Q Loss/Shr 85c >CRNX
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.